A Clinical Study to Evaluate the Safety and Tolerability of JS012 in Advanced or Metastatic Solid Tumors
Clinical trial NCT05388279 · TERMINATED
Trial details
- NCT number
- NCT05388279
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-28
- Primary completion
- 2022-09-19
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.